| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 44.43B | 43.95B | 45.02B | 44.24B | 35.01B | 28.26B |
| Gross Profit | 5.46B | 5.40B | 5.30B | 6.09B | 5.42B | 3.58B |
| EBITDA | 5.63B | 5.59B | 5.33B | 5.64B | 4.74B | 3.45B |
| Net Income | 1.95B | 2.00B | 2.12B | 2.63B | 2.21B | 1.36B |
Balance Sheet | ||||||
| Total Assets | 45.42B | 44.26B | 44.02B | 42.32B | 38.63B | 31.12B |
| Cash, Cash Equivalents and Short-Term Investments | 9.98B | 9.73B | 9.49B | 8.18B | 7.99B | 8.37B |
| Total Debt | 5.92B | 4.52B | 4.90B | 3.84B | 3.86B | 3.86B |
| Total Liabilities | 18.99B | 17.74B | 18.75B | 19.99B | 19.05B | 14.36B |
| Stockholders Equity | 23.34B | 23.46B | 22.41B | 19.98B | 17.56B | 15.09B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.48B | 302.00M | 543.00M | -407.00M | 3.94B |
| Operating Cash Flow | 0.00 | 5.48B | 3.90B | 4.02B | 1.82B | 4.99B |
| Investing Cash Flow | 0.00 | -4.00B | -3.56B | -3.49B | -2.24B | -1.07B |
| Financing Cash Flow | 0.00 | -894.00M | 711.00M | -409.00M | -228.00M | -33.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥15.87B | 17.10 | ― | 4.93% | 3.19% | 1.83% | |
72 Outperform | ¥16.90B | 7.44 | ― | 2.87% | 2.38% | -5.80% | |
71 Outperform | ¥10.97B | 15.68 | ― | 3.48% | 0.24% | 20.23% | |
69 Neutral | ¥7.57B | 4.62 | ― | 1.06% | 6.41% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | ¥23.17B | 10.25 | ― | 4.33% | 5.12% | ― | |
53 Neutral | ¥10.87B | -4.05 | ― | ― | -19.32% | -171.53% |